Currently, GenAns Biotech is conducting investigator-initiated trials for several gene therapies, including GA001 for ...

The Vision Center at Children’s Hospital Los Angeles is developing a protocol for a phase 1 clinical trial for the first gene therapy for boys with blue cone monochromacy, which impairs color vision ...

Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene-agnostic therapies for patients suffering severe vision loss from retinal degenerative ...

Technical Terms Opsin gene: A gene that encodes the protein component of visual pigments, essential for photoreception in the retina.